Anti-CD28 [9.3], Rabbit IgG, kappa
| Applications | Bl, ELISA, IF, IP |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-CD28 [9.3], Mouse IgG2a, kappa
| Applications | Bl, ELISA, IF, IP |
| Reactivities | Human |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
Recombinant Anti-TrkA (Clone MNAC13)
| Applications | Bl, ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-Glucose-dependent insulinotropic Receptor (Clone Gipg013)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Rat, Dog, Mouse |
Recombinant Anti-Glucose-dependent insulinotropic Receptor (Clone Gipg013)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Rat, Dog, Mouse |
Recombinant Anti-Human Muscle Acetylcholine Receptor (Clone mAb 192)
| Applications | Bl, ELISA, WB |
| Reactivities | Human, Mouse, Rat |
Recombinant Anti-TrkA (Clone MNAC13)
| Applications | Bl, ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-Notch 2 (Clone B6)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
Recombinant Anti-Notch 2 (Clone B9)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
Recombinant Anti-Notch 2 (Clone B6)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
Recombinant Anti-Notch 2 (Clone B9)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
Recombinant Anti-CD18 (Clone 60.3)
| Applications | Bl, ELISA, WB |
| Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC |
| Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC |
| Reactivities | Human |
United States
Germany
Japan
United Kingdom
China